Treatment of Corticosteroid-Refractory Alopecia Totalis with Oral Tacrolimus

The study explored the effectiveness of oral tacrolimus in treating corticosteroid-refractory alopecia totalis. The research was conducted by the Department of Dermatology at Princess Alexandra Hospital NHS Trust in Essex, UK. The findings suggested that oral tacrolimus could be a viable treatment option for patients who did not respond to corticosteroids, offering a potential alternative for managing this severe form of hair loss. However, the document did not provide specific details on the number of participants or the statistical outcomes, which are crucial for evaluating the strength of the study's conclusions.